- More Drug Reports. Helquist, Michael // Advocate;3/18/86, Issue 442, p25
Reports that researchers at the AIDS branch of the U.S. Centers for Disease Control continue to conduct tests of potentially therapeutic agents to be used against AIDS. Ability of rifabutin to block the in vitro infectivity and replication of the AIDS virus; Ability of rifabutin to penetrate...
- HALTING HIV. // Science Teacher;Sep2000, Vol. 67 Issue 6, p14
Reports that researchers have created a molecule, an HIV integrase inhibitor, that appears to survive in cells longer than existing treatments to combat the virus that leads to AIDS. Mechanism of action of the potential drug; Steps in the reproduction of HIV.
- Aids Drug Available In United Kingdom. Helquist, Michael // Advocate;1/19/88, Issue 490, p9
Reports on the availability in Great Britain AL-721, a drug for treating AIDS. Physicians' basis for prescribing the drug; Status in the United States; Start of the U.S. National Institutes of Health's study of its effectiveness against persistent generalized lymphadenopathy.
- CNE/CME QUESTIONS. // AIDS Alert;May2010, Vol. 25 Issue 5, p59
A quiz is presented related to medical care for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) patients.
- DIA GNOSIS DÃ‰ JÃ€ VU. Correia, Tony // Xtra West (Vancouver);1/28/2010, Issue 429, p12
The author shares his struggle of fighting HIV/AIDS virus infection on his own by not taking medications advised by physicians.
- Another AIDS teaser. Gorman, Christine; Sancton, Thomas A. // Time;11/8/1993, Vol. 142 Issue 19, p71
Recounts the announcement by biologist Ara Hovanessian (France's Pasteur Institute) that his research team had found a second receptor, CD26, that helps the HIV virus enter the cells of the immune system. Possible drug treatments to block access to the CD26 receptor, thus preventing infection;...
- Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic. Wambui, Veronica; Kiptoo, Michael; Kinyua, Joyceline; Odera, Irene; Muge, Edward; Muiruri, Peter; Lihana, Raphael; Kinyanjui, Peter; Songok, Elijah M. // AIDS Research & Therapy;2012, Vol. 9, p22
Background: CCR5 antagonists have clinically been approved for prevention or treatment of HIV/AIDS. Countries in Sub-Saharan Africa with the highest burden of HIV/AIDS are due to adopt these regimens. However, HIV-1 can also use CXCR4 as a co-receptor. There is hence an urgent need to map out...
- CNE/CME questions. // AIDS Alert;Feb2009, Vol. 24 Issue 2, p23
A quiz concerning the treatment for HIV and AIDS is presented.
- JUST SAY NO. Martindale, Diane // New Scientist;9/15/2001, Vol. 171 Issue 2308, p28
Discusses an AIDS therapy called 'structured treatment interruptions,' an on-again, off-again treatment regimen that allows the immune system to build to the point where it can hold the virus in check. Improvement in the quality of life of the patient; More affordable cost of the therapy;...